Nonviral regenerative gene therapy of mammalian cutaneous damages

The rate and character of superficial tissue regeneration after wounds, burns, and other traumas depend on cell proliferation within the damaged area. The acceleration of wound healing via the stimulation of cell proliferation and extracellular matrix synthesis is one of the most important tasks of modern medicine. There are gene therapy approaches to wound treatment, such as the transfer of genes that encode mitogenic growth factors to the wound area. The most important step in the development of the gene therapy approaches is the design of gene delivery tools. Despite the high efficiency of viral vectors, the nonviral approaches have some advantages (low toxicity, low immunogenity, safety, and the absence of side effects). Among the nonviral gene delivery tools molecular conjugates are the most popular due to their efficiency, simplicity, and the capacity for targeted gene transfer. In the present work, we have developed two molecular conjugates, NLS-TSF7 and NLS-TSF12, which consist of the modified signal of the nuclear localization of the T-antigen of the SV40 virus (cationic part) and the peptide ligands of the mammalian transferrin receptor (ligand part). Those conjugates bind to plasmid DNA via the formation of polyelectrolytic complexes and are able to deliver plasmid DNA into cells that express transferrin receptors through receptor-mediated endocytosis. The transfer of the expression vector of the luciferase gene in the complex with the molecular conjugate NLS-TSF7 to murine surface tissues led to about the 100-fold increase of luciferase activity in comparison with the transfer of the free expression vector. The treatment of mice with incised wounds with complexes of the expression vector of the synthetic human gene that encodes insulin-like growth factor 1 with molecular conjugate NLS-TSF7 led to the acceleration of wound healing in comparison with mice treated with the free expression vector. The obtained results confirm the high efficiency of the developed approach to regenerative gene therapy for treating the superficial tissue damage of mammals.     

The use of cryopreserved arteries as arterial vascular prostheses]

The aim of the study is investigation of possibility to bypass small and medium-size arteries with cryopreserved artery allografts, storing 7-10 days at -196 degrees C under the protection of 15% dimethylsulfoxide. In experiments on 40 rabbits were placed a region of the left renal artery by cryopreserved bioprosthesis. Graft patency was 80% after observation up to 6 months. By angiography it was 8 cases of graft thrombosis (all during the 1st week after implantation) and 5 cases of moderate graft dilation (in 4 of them it was accompanied with stenosis of distal anastomosis). In 20 dogs we replaced a region of the femoral artery by cryostoring bioprosthesis. It was only one case of graft thrombosis which occurred on month 2 after the implantation during 1-year follow-up. After 3 months in 3 cases there developed 3 cases of diffuse narrowing of graft lumen without decreasing of blood flow through the prosthesis. Later, the graft lumen did not change. Histological investigations have revealed a viability of cryopreserved vessels, its almost complete de-endothelialization at 3 days and total re-endothelialization 2 weeks after implantation. During the first 2 weeks there were morphological events of graft rejection, which disappeared after 3 months.     

Transfer of genetic constructions through the transplacental barrier into mice embryos

Genetic modification of mammalian embryos is an important way to model various changes in human development; also, it is an instrument for studying the functions of certain genes in mammals. Using our own experience in developing modes of delivery of genetic constructions to mammals in a nonviral way, we present here data on the delivery of a eukaryotic expression vector to mice embryos through the transpla-cental barrier with the use of hydrodynamic intravenous injections of DNA-hybrid peptide complexes to pregnant females. The peptide has a cationic part for interaction with DNA and includes a ligand structure towards receptors of the releasing factor of luteinizing hormone (RFLH, luliberin). Advantages of the suggested method are simplicity, economy, nonimmunogenicity for females, and the ability to multiply repeat the procedure. On the basis of the method, systemic gene delivery into tissues of mammalian embryos may be developed.     

A functional state of the sphingomyelin cycle and activity of free radical oxidation of rat liver lipids at different phases of starvation

A functional state of the sphingomyeline cycle and its links with processes of free radical lipid oxidation have been investigated in rat liver during starvation of animals without any restriction of access to drinking water at day 1, 2, 3 (phase I) and day 6 (phase II of starvation). The maximal values of the ceramide/sphingomyelin ratio and activities of neutral sphingomyelinase and executive caspase-3 were found in rat livers at day 3 of starvation. Since day 3 of starvation an increase of tumour necrosis factor-α, one of neutral sphingomyelinase activators, was detected in serum. During the major part of phase I of starvation the intensity of liver free radical lipid peroxidation was comparable to that of control due to competent functioning of the antioxidant defense system. Transition of phase I to phase II of starvation (day 6 of the experiment) was accompanied by the development of oxidative stress associated with depletion of the antioxidant defense system. The results obtained in this study suggest that phase I of starvation favors realization of the ceramide-mediated proapoptotic signaling in the liver. In our viewpoint, ceramide-mediated apoptosis is one of mechanisms used optimization of liver cellular population within the frame of metabolic adaptation. In rat liver phase I of starvation was characterized by prevailing of the ceramide-mediated proapoptotic signaling, while in phase II oxidative stress dominated.     

Structures of the Mouse Central Nervous System Contain Different Quantities of Proteasome Gene Transcripts

Molecular Biology - Proteasomes are multisubunit complexes that degrade most intracellular proteins. Three of the 14 subunits of the 20S proteasome, specifically β1, β2, and...